Diagnostic Hybrids Overview

  • Founded
  • 1982

  • Status
  • Acquired/​Merged

  • Employees
  • 220

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $131M

Diagnostic Hybrids General Information


Developer of diagnostic cell cultures and virus detection kit systems used in the clinical diagnosis of infectious and autoimmune diseases. The company offers D3 FastPoint L-DFA influenza A/influenza B virus identification kit, which allows for the identification of influenza A virus and influenza B virus from a patient's specimen. It also develops and commercializes genetically engineered cell-based detection products for the pharmaceutical and biotechnology industry with a focus on pharmacology assays and products that measure drug clearance and anti-viral interventions with drugs and vaccines.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 350 West State Street
  • Athens, OH 45701
  • United States
+1 (740) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Diagnostic Hybrids Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 19-Feb-2010 $131M 0000 00000 Completed Generating Revenue
1. Later Stage VC 11-Aug-2004 0000 0000 Completed Generating Revenue
To view Diagnostic Hybrids’s complete valuation and funding history, request access »

Diagnostic Hybrids Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Diagnostic Hybrids Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kenson Ventures Venture Capital Minority 000 0000 000000 0
Summit Partners PE/Buyout Minority 000 0000 000000 0
To view Diagnostic Hybrids’s complete investors history, request access »